Hinterleitner C - Search Results

1

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells.

Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Märklin M, Kopp HG, Salih HR. Maurer S, et al. Among authors: hinterleitner c. Oncoimmunology. 2017 Nov 27;7(2):e1364827. doi: 10.1080/2162402X.2017.1364827. eCollection 2018. Oncoimmunology. 2017. PMID: 29308299 Free PMC article.

2

Low plasma protein Z levels are associated with an increased risk for perioperative bleedings.

Hinterleitner C, Kreisselmeier KP, Pecher AC, Mauz PS, Kanz L, Kopp HG, Jaschonek KG. Hinterleitner C, et al. Eur J Haematol. 2018 May;100(5):403-411. doi: 10.1111/ejh.13031. Epub 2018 Mar 26. Eur J Haematol. 2018. PMID: 29360177

3

Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient.

Hinterleitner C, Steurer M, Dörfel D, Heitmann J, Kreisselmeier KP, Müller K, Kopp HG, Wirths S, Haap M, de Fend LQ, Horger M, Rodriguez-Galindo C, Kanz L, Müller MR. Hinterleitner C, et al. Ann Hematol. 2019 Jan;98(1):227-230. doi: 10.1007/s00277-018-3421-7. Epub 2018 Jul 6. Ann Hematol. 2019. PMID: 29980874 No abstract available.

4

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia.

Fuchs AR, Märklin M, Heitmann JS, Futterknecht S, Haap M, Wirths S, Kopp HG, Hinterleitner C, Dörfel D, Müller MR. Fuchs AR, et al. Among authors: hinterleitner c. J Vis Exp. 2018 Dec 4;(142). doi: 10.3791/58270. J Vis Exp. 2018. PMID: 30582586

5

Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.

Clar KL, Hinterleitner C, Schneider P, Salih HR, Maurer S. Clar KL, et al. Among authors: hinterleitner c. Cancers (Basel). 2019 Feb 26;11(3):277. doi: 10.3390/cancers11030277. Cancers (Basel). 2019. PMID: 30813611 Free PMC article.

6

Disease progression and defects in primary hemostasis as major cause of bleeding in multiple myeloma.

Hinterleitner C, Pecher AC, Kreißelmeier KP, Budde U, Kanz L, Kopp HG, Jaschonek K. Hinterleitner C, et al. Eur J Haematol. 2020 Jan;104(1):26-35. doi: 10.1111/ejh.13331. Epub 2019 Dec 5. Eur J Haematol. 2020. PMID: 31541609

7

CD105 (Endoglin) as negative prognostic factor in AML.

Kauer J, Schwartz K, Tandler C, Hinterleitner C, Roerden M, Jung G, Salih HR, Heitmann JS, Märklin M. Kauer J, et al. Among authors: hinterleitner c. Sci Rep. 2019 Dec 4;9(1):18337. doi: 10.1038/s41598-019-54767-x. Sci Rep. 2019. PMID: 31797971 Free PMC article.

8

Identification of CD318 (CDCP1) as novel prognostic marker in AML.

Heitmann JS, Hagelstein I, Hinterleitner C, Roerden M, Jung G, Salih HR, Märklin M, Kauer J. Heitmann JS, et al. Among authors: hinterleitner c. Ann Hematol. 2020 Mar;99(3):477-486. doi: 10.1007/s00277-020-03907-9. Epub 2020 Jan 21. Ann Hematol. 2020. PMID: 31965270 Free PMC article.

9

CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation.

Märklin M, Hagelstein I, Hinterleitner C, Salih HR, Kauer J, Heitmann JS. Märklin M, et al. Among authors: hinterleitner c. Int J Hematol. 2020 Jul;112(1):57-64. doi: 10.1007/s12185-020-02875-0. Epub 2020 Apr 7. Int J Hematol. 2020. PMID: 32266669

10

A novel flow cytometry-based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemia.

Heitmann JS, Märklin M, Truckenmüller FM, Hinterleitner C, Dörfel D, Haap M, Kopp HG, Wirths S, Müller MR. Heitmann JS, et al. Among authors: hinterleitner c. J Leukoc Biol. 2020 Dec;108(6):1851-1857. doi: 10.1002/JLB.5TA0320-411RR. Epub 2020 Apr 17. J Leukoc Biol. 2020. PMID: 32303123 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters